MRSA Drugs Market 2023: Share, Size, Leading Players, Global Industry Analysis, Future Scope and Business Opportunities by 2028
According to IMARC Group’s latest report, titled "MRSA Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", The global MRSA drugs market size reached US$ 3.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2028, exhibiting a growth rate (CAGR) of 3.6% during 2023-2028. Year Considered to Estimate the Market Size: Base Year of the Analysis: 2022 Historical Period: 2017-2022 Forecast Period: 2023-2028 MRSA Drugs Market Overview: Methicillin-resistant Staphylococcus aureus (MRSA) represents an infection caused by antibiotic-resistant strains of staphylococcus aureus that commonly occurs in patients who receive intravenous tubing, undergo surgical procedures, or come in contact with each other skin-to-skin. The medicines are used as antimicrobial agents against methicillin-resistant staphylococcus aureus infection to kill or restrain it. The most common MRSA drugs consist of clindamycin, mino...